Vitamin D resistance and colon cancer prevention

Carcinogenesis

Volumn 33, Issue 3, 2012, Pages 475-482

  Giardina, Charles ^a   Madigan, James P ^b   Godman Tierney, Cassandra A ^a   Brenner, Bruce M ^b   Rosenberg, Daniel W ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; INTERLEUKIN 1BETA; PROTEIN BAX; UVOMORULIN; VITAMIN D; VITAMIN D RECEPTOR; WNT PROTEIN;

ANTINEOPLASTIC ACTIVITY; CANCER MORTALITY; CANCER PREVENTION; CANCER RESISTANCE; CELL DIFFERENTIATION; CHEMOPROPHYLAXIS; CHROMATIN STRUCTURE; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; COLON POLYP; COLORECTAL CARCINOMA; DIET; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; GENE ACTIVATION; GENE SILENCING; HIGH RISK POPULATION; HISTONE ACETYLATION; HUMAN; METASTASIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; RISK REDUCTION; SIGNAL TRANSDUCTION; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 84857936919     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr301     Document Type: Review

References (138)

1. Richardson,L.C. et al. (2011) Vital signs: colorectal cancer screening, incidence, and mortality-United States, 2002-2010. MMWR Morb. Mortal. Wkly Rep., 60, 884-889.
2. Edwards,B.K. et al. (2010) Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer, 116, 544-573.
3. Nelson,R.S. et al. (2009) Colorectal cancer screening. Curr. Oncol. Rep., 11, 482-489.
4. Cuzick,J. et al. (2009) Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol., 10, 501-507.
5. Chan,A.T. et al. (2008) Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology, 134, 21-28.
6. Hawk,E.T. et al. (2005) Colorectal cancer prevention. J. Clin. Oncol., 23, 378-391.
7. Garland,C.F. et al. (1980) Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol., 9, 227-231.
8. McCullough,M.L. et al. (2003) Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States). Cancer Causes Control, 14, 1-12.
9. Lieberman,D.A. et al. (2003) Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA, 290, 2959-2967.
10. Freedman,D.M. et al. (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J. Natl Cancer Inst., 99, 1594-1602.
11. Huncharek,M. et al. (2009) Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutr. Cancer, 61, 47-69.
12. Lin,J. et al. (2005) Intakes of calcium and vitamin D and risk of colorectal cancer in women. Am. J. Epidemiol., 161, 755-764.
13. Terry,P. et al. (2002) Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in women. Nutr. Cancer, 43, 39-46.
14. Kawaura,A. et al. (1990) 1 Alpha-hydroxyvitamin D3 suppresses colonic tumorigenesis induced by repetitive intrarectal injection of N-methyl-N-nitrosourea in rats. Cancer Lett., 55, 149-152.
15. Oda,M. et al. (1990) Effects of 1 alpha-hydroxyvitamin D3 on N-methyl-N-nitrosourea-induced colonic tumorigenesis, and on fecal bile acid profiles with respect to soluble and precipitated phases in rats. Tokushima J. Exp. Med., 37, 75-81.
16. Kawaura,A. et al. (1989) Supplemental administration of 1 alpha-hydroxyvitamin D3 inhibits promotion by intrarectal instillation of lithocholic acid in N-methyl-N-nitrosourea-induced colonic tumorigenesis in rats. Carcinogenesis, 10, 647-649.
17. Kawaura,A. et al. (1998) Inhibitory effect of 1alpha-hydroxyvitamin D3 on N-methyl-N'-nitro-N-nitrosoguanidine-induced gastrointestinal carcinogenesis in Wistar rats. Cancer Lett., 122, 227-230.
18. Belleli,A. et al. (1992) A protective role of 1,25-dihydroxyvitamin D3 in chemically induced rat colon carcinogenesis. Carcinogenesis, 13, 2293-2298.
19. Sitrin,M.D. et al. (1991) Dietary calcium and vitamin D modulate 1,2-dimethylhydrazine-induced colonic carcinogenesis in the rat. Cancer Res., 51, 5608-5613.
20. Pence,B.C. et al. (1988) Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis, 9, 187-190.
21. Kawaura,A. et al. (1992) Suppression of colonic carcinogenesis by vitamin D in rats. J. Nutr. Sci. Vitaminol. (Tokyo), 331-332.
22. Seino,Y. et al. (1987) Circulating 1 alpha,25-dihydroxyvitamin D levels after a single dose of 1 alpha,25-dihydroxyvitamin D3 or 1 alphahydroxyvitamin D3 in normal men. Bone Miner., 2, 479-485.
23. Newmark,H.L. et al. (2009) Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis, 30, 88-92.
24. Yang,K. et al. (2008) Dietary induction of colonic tumors in a mouse model of sporadic colon cancer. Cancer Res., 68, 7803-7810.
25. Newmark,H.L. et al. (2001) A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis, 22, 1871-1875.
26. Yang,K. et al. (2008) Dietary calcium and cholecalciferol modulate cyclin D1 expression, apoptosis, and tumorigenesis in intestine of adenomatous polyposis coli1638N/+ mice. J. Nutr., 138, 1658-1663.
27. Huerta,S. et al. (2003) Intestinal polyp formation in the Apcmin mouse: effects of levels of dietary calcium and altered vitamin D homeostasis. Dig. Dis. Sci., 48, 870-876.
28. Huerta,S. et al. (2002) 1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) mouse. Cancer Res., 62, 741-746.
29. Fedirko,V. et al. (2009) Effects of vitamin D and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trial. Cancer Epidemiol. Biomarkers Prev., 18, 2933-2941.
30. Fajkus,J. et al. (2003) Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells. Anticancer Res., 23, 1605-1612.
31. Fedirko,V. et al. (2009) Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, doubleblind, placebo-controlled clinical trial. Cancer Prev. Res. (Phila), 2, 213-223.
32. Hartman,T.J. et al. (2005) The association of calcium and vitamin D with risk of colorectal adenomas. J. Nutr., 135, 252-259.
33. Wactawski-Wende,J. et al. (2006) Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med., 354, 684-696.
34. Michels, K.B. (2006) The women's health initiative-curse or blessing? Int. J. Epidemiol., 35, 814-816.
35. Sinicrope,F.A. (2006) Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer. Mol. Carcinog., 45, 447-454.
36. Bertagnolli,M.M. (2007) Chemoprevention of colorectal cancer with cyclooxygenase-2 inhibitors: two steps forward, one step back. Lancet Oncol., 8, 439-443.
37. Bertagnolli,M.M. et al. (2006) Celecoxib for the prevention of sporadic colorectal adenomas. N. Engl. J. Med., 355, 873-884.
38. Sone,T. et al. (1991) Vitamin D receptor interaction with specific DNA. Association as a 1,25-dihydroxyvitamin D3-modulated heterodimer. J. Biol. Chem., 266, 23296-23305.
39. Kimmel-Jehan,C. et al. (1997) Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor- vitamin D-responsive element complex formation. Arch. Biochem. Biophys., 341, 75-80.
40. Ing,N.H. et al. (1992) Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J. Biol. Chem., 267, 17617-17623.
41. MacDonald,P.N. et al. (1995) The vitamin D receptor interacts with general transcription factor IIB. J. Biol. Chem., 270, 4748-4752.
42. Blanco,J.C. et al. (1995) Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc. Natl Acad. Sci. USA, 92, 1535-1539.
43. Mizwicki,M.T. et al. (2004) Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling. Proc. Natl Acad. Sci. USA, 101, 12876-12881.
44. Zhou,L.X. et al. (1995) 1 alpha,25(OH)2-vitamin D3 analog structurefunction assessment of intestinal nuclear receptor occupancy with induction of calbindin-D28K. Endocrinology, 136, 1145-1152.
45. Nemere,I. et al. (1994) Identification of a specific binding protein for 1 alpha,25-dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia. J. Biol. Chem., 269, 23750-23756.
46. Barsony,J. et al. (1991) Rapid accumulation of cyclic GMP near activated vitamin D receptors. Proc. Natl Acad. Sci. USA, 88, 1436-1440.
47. Ramagopalan,S.V. et al. (2010) A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res., 20, 1352-1360.
48. Meyer,M.B. et al. (2010) Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone. J. Steroid Biochem. Mol. Biol., 121, 136-141.
49. Tagami,T. et al. (1998) The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Biochem. Biophys. Res. Commun., 253, 358-363.
50. Leong,G.M. et al. (2004) Ski-interacting protein, a bifunctional nuclear receptor coregulator that interacts with N-CoR/SMRTand p300. Biochem. Biophys. Res. Commun., 315, 1070-1076.
51. Jimenez-Lara,A.M. et al. (1999) The vitamin D receptor binds in a transcriptionally inactive form and without a defined polarity on a retinoic acid response element. FASEB J., 13, 1073-1081.
52. Ting,H.J. et al. (2007) Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1alpha, 25-dihydroxyvitamin D3 responsiveness. Mol. Cancer Res., 5, 967-980.
53. Ting,H.J. et al. (2005) Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity. Endocrine, 26, 1-9.
54. Abedin,S.A. et al. (2009) Elevated NCOR1 disrupts a network of dietarysensing nuclear receptors in bladder cancer cells. Carcinogenesis, 30, 449-456.
55. Abedin,S.A. et al. (2006) Epigenetic corruption of VDR signalling in malignancy. Anticancer Res., 26, 2557-2566.
56. Weichert,W. et al. (2008) Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin. Cancer Res., 14, 1669-1677.
57. Mariadason,J.M. (2008) HDACs and HDAC inhibitors in colon cancer. Epigenetics, 3, 28-37.
58. Spurling,C.C. et al. (2008) HDAC3 overexpression and colon cancer cell proliferation and differentiation. Mol. Carcinog., 47, 137-147.
59. Nakagawa,M. et al. (2007) Expression profile of class I histone deacetylases in human cancer tissues. Oncol. Rep., 18, 769-774.
60. Wilson,A.J. et al. (2006) Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J. Biol. Chem., 281, 13548-13558.
61. Fraga,M.F. et al. (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet., 37, 391-400.
62. Godman,C.A. et al. (2008) HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling. Cancer Biol. Ther., 7, 1570-1580.
63. Heery,D.M. et al. (1997) A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature, 387, 733-736.
64. Masuyama,H. et al. (1997) Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol. Endocrinol., 11, 1507-1517.
65. Rachez,C. et al. (1999) Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature, 398, 824-828.
66. Rachez,C. et al. (1998) A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev., 12, 1787-1800.
67. MacDonald,P.N. et al. (2004) Emerging insights into the coactivator role of NCoA62/SKIP in Vitamin D-mediated transcription. J. Steroid Biochem. Mol. Biol., 89-90, 179-186.
68. Zhang,C. et al. (2003) Nuclear coactivator-62 kDa/Ski-interacting protein is a nuclear matrix-associated coactivator that may couple vitamin D receptor-mediated transcription and RNA splicing. J. Biol. Chem., 278, 35325-35336.
69. McKenna,N.J. et al. (1999) Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev., 20, 321-344.
70. Lanz,R.B. et al. (1999) A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell, 97, 17-27.
71. Liu,Z. et al. (2001) Sequential recruitment of steroid receptor coactivator-1 (SRC-1) and p300 enhances progesterone receptor-dependent initiation and reinitiation of transcription from chromatin. Proc. Natl Acad. Sci. USA, 98, 12426-12431.
72. Utley,R.T. et al. (1998) Transcriptional activators direct histone acetyltransferase complexes to nucleosomes. Nature, 394, 498-502.
73. Spencer,T.E. et al. (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature, 389, 194-198.
74. Jenster,G. et al. (1997) Steroid receptor induction of gene transcription: a two-step model. Proc. Natl Acad. Sci. USA, 94, 7879-7884.
75. Colston,K.W. et al. (1977) Feedback regulation of vitamin D metabolism by 1,25-dihydroxycholecalciferol. Biochem. J., 164, 83-89.
76. Turunen,M.M. et al. (2007) Selective use of multiple vitamin D response elements underlies the 1 alpha,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene. Nucleic Acids Res., 35, 2734-2747.
77. Murayama,A. et al. (2004) Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J., 23, 1598-1608.
78. Yuan,W. et al. (2007) 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J. Biol. Chem., 282, 29821-29830.
79. Huang,Y.C. et al. (2006) 1,25-dihydroxyvitamin D3 transcriptionally represses p45Skp2 expression via the Sp1 sites in human prostate cancer cells. J. Cell. Physiol., 209, 363-369.
80. Evans,S.R. et al. (1998) Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer. Clin. Cancer Res., 4, 1591-1595.
81. Kane,K.F. et al. (1996) Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid. Cancer Res., 56, 623-632.
82. Kane,K.F. et al. (1995) 1,25-Dihydroxyvitamin D3 and retinoid X receptor expression in human colorectal neoplasms. Gut, 36, 255-258.
83. Cross,H.S. et al. (1996) Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer. Anticancer Res., 16, 2333-2337.
84. Vandewalle,B. et al. (1994) 1,25-dihydroxyvitamin D3 receptors in normal and malignant human colorectal tissues. Cancer Lett., 86, 67-73.
85. Sheinin,Y. et al. (2000) In situ mRNA hybridization analysis and immunolocalization of the vitamin D receptor in normal and carcinomatous human colonic mucosa: relation to epidermal growth factor receptor expression. Virchows Arch., 437, 501-507.
86. Matusiak,D. et al. (2005) Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxylase in normal and malignant human colon. Cancer Epidemiol. Biomarkers Prev., 14, 2370-2376.
87. Larriba,M.J. et al. (2009) Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer. Carcinogenesis, 30, 1459-1468.
88. Larriba,M.J. et al. (2005) SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications. Br. J. Cancer, 92, 985-989.
89. Palmer,H.G. et al. (2004) The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat. Med., 10, 917-919.
90. Nieto, M.A. (2002) The snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell Biol., 3, 155-166.
91. Batlle,E. et al. (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol., 2, 84-89.
92. Cano,A. et al. (2000) The transcription factor snail controls epithelial- mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol., 2, 76-83.
93. Carver,E.A. et al. (2001) The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol. Cell. Biol., 21, 8184-8188.
94. Yokoyama,K. et al. (2001) Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol., 37, 65-71.
95. Pena,C. et al. (2005) E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum. Mol. Genet., 14, 3361-3370.
96. Pena,C. et al. (2009) SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue. Oncogene, 28, 4375-4385.
97. Hajra,K.M. et al. (2002) The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res., 62, 1613-1618.
98. Peinado,H. et al. (2004) Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol. Cell. Biol., 24, 306-319.
99. Herranz,N. et al. (2008) Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor. Mol. Cell. Biol., 28, 4772-4781.
100. Hong,S. et al. (2007) Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc. Natl Acad. Sci. USA, 104, 18439-18444.
101. Marik,R. et al. (2010) DNA methylation-related vitamin D receptor insensitivity in breast cancer. Cancer Biol. Ther., 10, 44-53.
102. Wada,K. et al. (2009) Vitamin D receptor expression is associated with colon cancer in ulcerative colitis. Oncol. Rep., 22, 1021-1025.
103. Dong,R. et al. (2007) Role of nuclear factor kappa B and reactive oxygen species in the tumor necrosis factor-alpha-induced epithelial- mesenchymal transition of MCF-7 cells. Braz. J. Med. Biol. Res., 40, 1071-1078.
104. Zhou,C. et al. (2008) Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial- mesenchymal transition phenotype. Breast Cancer Res., 10, R105.
105. Zavadil,J. et al. (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene, 24, 5764-5774.
106. Peinado,H. et al. (2003) Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J. Biol. Chem., 278, 21113-21123.
107. Froicu,M. et al. (2007) Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol., 8, 5.
108. Froicu,M. et al. (2006) Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. Immunology, 117, 310-318.
109. Kaler,P. et al. (2009) Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene, 28, 3892-3902.
110. Essa,S. et al. (2010) VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells. J. Steroid Biochem. Mol. Biol., 121, 110-113.
111. Mohri,T. et al. (2009) MicroRNA regulates human vitamin D receptor. Int. J. Cancer, 125, 1328-1333.
112. Baffa,R. et al. (2009) MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J. Pathol., 219, 214-221.
113. Mulholland,D.J. et al. (2005) Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr. Rev., 26, 898-915.
114. Palmer,H.G. et al. (2001) Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J. Cell Biol., 154, 369-387.
115. Pendas-Franco,N. et al. (2008) Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Anticancer Res., 28, 2613-2623.
116. Shah,S. et al. (2006) The molecular basis of vitamin D receptor and betacatenin crossregulation. Mol. Cell, 21, 799-809.
117. Beildeck,M.E. et al. (2009) Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines. PLoS One, 4, e7872.
118. Zheng,W. et al. (2012) Inactivation of the vitamin D receptor in APC(min/+) mice reveals a critical role for the vitamin D receptor in intestinal tumor growth. Int. J. Cancer, 130, 10-19.
119. Powell,S.M. et al. (1992) APC mutations occur early during colorectal tumorigenesis. Nature, 359, 235-237.
120. Luderer,H.F. et al. (2011) Lymphoid enhancer-binding factor-1 (LEF1) interacts with the DNA-binding domain of the vitamin D receptor. J. Biol. Chem., 286, 18444-18451.
121. Cianferotti,L. et al. (2007) Vitamin D receptor is essential for normal keratinocyte stem cell function. Proc. Natl Acad. Sci. USA, 104, 9428-9433.
122. de Lau,W. et al. (2001) LEF1 turns over a new leaf. Nat. Genet., 28, 3-4.
123. Atcha,F.A. et al. (2003) A new beta-catenin-dependent activation domain in T cell factor. J. Biol. Chem., 278, 16169-16175.
124. Hovanes,K. et al. (2001) Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat. Genet., 28, 53-57.
125. Sanchez-Martinez,R. et al. (2006) The retinoid X receptor ligand restores defective signalling by the vitamin D receptor. EMBO Rep., 7, 1030-1034.
126. Volate,S.R. et al. (2009) Epigenetic modulation of the retinoid X receptor alpha by green tea in the azoxymethane-Apc Min/+ mouse model of intestinal cancer. Mol. Carcinog., 48, 920-933.
127. Egan,J.B. et al. (2010) Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. Cancer Res., 70, 1496-1504.
128. Meyskens,F.L. Jr et al. (2005) Diet and cancer: the disconnect between epidemiology and randomized clinical trials. Cancer Epidemiol. Biomarkers Prev., 14, 1366-1369.
129. Cross,H.S. et al. (2009) Regulation of the colonic vitamin D system for prevention of tumor progression: an update. Future Oncol., 5, 493-507.
130. Horvath,H.C. et al. (2010) The candidate oncogene CYP24A1: a potential biomarker for colorectal tumorigenesis. J. Histochem. Cytochem., 58, 277-285.
131. Bareis,P. et al. (2001) 25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression. Biochem. Biophys. Res. Commun., 285, 1012-1017.
132. Cross,H.S. et al. (2001) 25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids, 66, 287-292.
133. Matusiak,D. et al. (2007) CYP27A1 and CYP24 expression as a function of malignant transformation in the colon. J. Histochem. Cytochem., 55, 1257-1264.
134. Anderson,M.G. et al. (2006) Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother. Pharmacol., 57, 234-240.
135. Barycki,R. et al. (2009) Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD) selectively eliminates bone calcium mobilization activity. Bioorg. Med. Chem., 17, 7658-7669.
136. Schuster,I. et al. (2006) Selective inhibitors of vitamin D metabolism- new concepts and perspectives. Anticancer Res., 26, 2653-2668.
137. Schuster,I. et al. (2003) Inhibitors of vitamin D hydroxylases: structureactivity relationships. J. Cell Biochem., 88, 372-380.
138. Muindi,J.R. et al. (2010) CYP24A1 inhibition enhances the antitumor activity of calcitriol. Endocrinology, 151, 4301-4312.